Quintupling inhaled glucocorticoids to prevent childhood asthma exacerbations

D. Jackson (Madison, United States of America)

Source: International Congress 2018 – Preventing asthma and COPD exacerbations by increasing the inhaled glucocorticoid dose
Disease area: Airway diseases

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Jackson (Madison, United States of America). Quintupling inhaled glucocorticoids to prevent childhood asthma exacerbations. International Congress 2018 – Preventing asthma and COPD exacerbations by increasing the inhaled glucocorticoid dose

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
An economic evaluation of adding inhaled corticosteroids to systemic corticosteroids for treating acute asthma exacerbations
Source: International Congress 2019 – Severe acute asthma and troublesome wheezing
Year: 2019

Inhaled budesonide for the treatment of chronic wheezing in early childhood
Source: Eur Respir J 2003; 22: Suppl. 45, 132s
Year: 2003

Could montelukast reduce asthma exacerbations?
Source: Annual Congress 2008 - Advances in the treatment and pathogenesis of pulmonary diseases
Year: 2008

Inhaled corticosteroids in the treatment of acute asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 305s
Year: 2002

The role of inhaled corticosteroids in the management of acute asthma
Source: Eur Respir J 2007; 30: 1035-1037
Year: 2007


Severe exacerbations, decline in lung function and inhaled budesonide in asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 619s
Year: 2007

Quadrupling the inhaled glucocorticoid dose to abort asthma exacerbations
Source: International Congress 2018 – Preventing asthma and COPD exacerbations by increasing the inhaled glucocorticoid dose
Year: 2018


Childhood asthma and responses to inhaled bronchodilating agents during early wheezing
Source: Eur Respir J 2005; 26: Suppl. 49, 625s
Year: 2005

Utility of aerosolized budesonide therapy in acute moderate exacerbations of asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 283s
Year: 2003

Inhaled steroids in exacerbations of COPD
Source: Eur Respir J 2007; 30: 398
Year: 2007


Estimate of asthma control and adherence to inhaled corticosteroids in children with asthma
Source: Annual Congress 2010 - Managing asthma and allergic disease in children
Year: 2010


Effects of inhaled corticosteroids on cough in asthma patients
Source: Eur Respir J 2004; 24: Suppl. 48, 347s
Year: 2004

Long-term adherence to inhaled corticosteroids and asthma control in adult-onset asthma
Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Year: 2020


Oral corticosteroids in the treatment of exacerbation of severe asthma
Source: Virtual Congress 2020 – Exhaled biomarkers of asthma and the asthma burden
Year: 2020


To assess the effects of combined nasal and inhaled corticosteroid in patients with asthma and persistent allergic rhinitis
Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases
Year: 2009

Persistent airway inflammation in young allergic wheezing children treated with inhaled corticosteroids
Source: Annual Congress 2003 - Current issues on wheezing in infancy
Year: 2003


Inhaled corticosteroids and hospitalisation due to exacerbation of COPD
Source: Eur Respir J 2003; 22: 286-289
Year: 2003



The importance of early applying inhaled corticosteroids in patients with mild bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 57s
Year: 2002

Determinants of adherence to inhaled corticosteroids in children with asthma
Source: Annual Congress 2010 - Managing asthma and allergic disease in children
Year: 2010


Utility of high dose inhaled fluticasone therapy for the early management of acute exacerbations of asthma
Source: Annual Congress 2009 - Next generation bronchodilators
Year: 2009